9 REFERENCES
J. Pharm., 86, 137-145 (1992)
178. Landau, E. M. and Luigi Luisi, P., Lipidic cubic phases as transparent, rigid matrices for the direct spectroscopic study of immobilized membrane proteins, /. Am. Chem.
Soc, 115, 2102-2106 (1993).
179. Landh, T., From entangled membranes to eclectic morphologies: cubic membranes as subcellular space organizers, FEBS Lett., 369, 13-17 (1995).
180. Larsson, K., Cubic lipid-water phases: structures and biomembrane aspects, J. Phys. Chem., 93, 7304-7314 (1989).
181. Landh, T., Phase behavior in the system pine oil monoglycerides-poloxamer 407-water at 20°C, J. Phys.
Chem., 98, 8453-8467 (1994).
182. Ericsson, B., Larsson, K. and Fontell, K., A cubic protein -monoolein- water phase, Biochim. Biophys.
Acta, 729, 23-27 (1983).
183. Portmann, M., Landau, E. M. and Luisi, P. L., Spectro-scopic and rheological studies of enzymes in rigid lipidic matrices: the case of /3-chymotrypsin in a lysolecithin/water cubic phase, J. Phys. Chem., 95, 8437-8440 (1991).
184. Razumas, V., Larsson, K., Miezis, Y. and Nylander, T., A cubic monoolein-cytochrome c-water phase: X-ray diffraction, FT-IR, differential scanning calorimetric, and electrochemical studies, J. Phys. Chem., 100, 11766-11774 (1996).
185. Razumas, V., Kanapieniene, J., Nylander, T., Eng-strom, S. and Larsson, K., Electrochemical biosensors for glucose, lactate, urea, and creatinine based on enzymes entrapped in a cubic liquid crystalline phase, Anal. Chem.
Acta, 289, 155-162(1994).
186. Hadgraft, J., Williams, D. G. and Allan, G., Azone.
Mechanisms of action and clinical effect, Drugs Pharm.
ScL, 59, 175-197 (1993).
187. Alexandridis, P., Olsson, U. and Lindman, B., Self-assembly of amphiphilic block copolymers: the (EO) 13-(PO)3o(EO)i3-water-/?-xylene system, Macromolecules, 28, 7700-7710 (1995).
188. Alexandridis, P., Olsson, U. and Lindman, B., Phase behaviour of amphiphilic block copolymers in water-oil mixtures: the Pluronic 25R4 - water- /?-xylene system, /.
Phys. Chem., 100, 280-288 (1996).
189. Wang, P.-L. and Johnston, T. P., Sustained-release inter-leukin-2 following intramuscular injection in rats, Int. J.
Pharm., 113, 73-81 (1995).
190. Tomida, H., Kuwada, N. and Kiryu, S., Hydrolysis of indomethacin in Pluronic F-127 gels, Acta Pharm. Suec, 25, 87-96 (1988).
191. Nalbandian, R. M., Henry, R. L. and Wilks, H. S., Arti-ficial skin. II. Pluronic F-127 silver nitrate or silver lactate gel in treatment of thermal burns, J. Biomed. Mater. Res., 6, 583-590 (1972).
192. Piculell, L., Gelling polysaccharides, Curr. Opinion Colloid Interface ScL, 3, 643-650 (1998).
193. Morris, V. J. and Wilde, P. J., Interactions of food biopolymers, Curr. Opinion Colloid Interface ScL, 2, 567-572 (1997).
194. Clark, A. H. and Ross-Murphy, S. B., Structural and mechanical properties of biopolymer gels, Adv. Polym.
ScL, 83, 57-192 (1987).
195. Piculell, L. and Nilsson, S., Effects of salt on association and conformational equilibria of macromolecules in solution, Prog. Colloid Polym. ScL, 82, 198-210 (1990).
196. Hovgaard, L. and Br0ndsted, H., Current applications of polysaccharides in colon targeting, CHt. Rev. Ther. Drug Carrier SySt., 13, 185-223 (1996).
197. Hwang, S.-J., Park, H. and Park, K., Gastric retentive drug-delivery systems, CHt. Rev. Ther. Drug Carrier Syst., 15, 243-284 (1998).
198. Kedzierewicz, F., Lombry, C , Rios, R., Hoffman, M.
and Maincent, P., Effect of the formulation on the in-vitro release of propranolol from gellan beads, Int. J. Pharm., 178, 129-136 (1999).
199. Kwak, J. C. T., Polymer-Surfactant Systems, Surface Science Series Vol. 77, Marcel Dekker, New York, 1998.
200. Goddard, E. D. and Ananthapadmanabhan, K. P. (Eds), Interactions of Surfactants with Polymers and Proteins, CRC Press, Boca Raton, FL, 1993.
201. Iliopoulos, L, Wang, T. K. and Audebert, R., Viscometric evidence of interaction between hydrophobically modi-fied poly(sodium acrylate) and sodium dodecyl sulfate, Langmuir, 7, 617-619 (1991).
202. Lindell, K. and Engstrom, S., In vitro release of timolol maleate from an in situ gelling polymer system, Int. J.
Pharm., 95, 219-228 (1993).
203. Lindell, K. and Engstrom, S., Investigation of surfactant alkyl chain length and counterion effects on the thermogelling EHEC system, Int. J. Pharm., 124, 107-118 (1995).
204. Schmolka, I. R., Poloxamers in the pharmaceutical industry, in Polymers for Controlled Drug Delivery, Tarcha, P. J., (Ed.), CRC Press, Boca Raton, FL, 1991, pp. 189-214.
205. Schild, H. G., Poly(A^-isopropylacrylamide): experiment, theory and application, Prog. Polym. ScL, 17, 163-249 (1992).
206. Fleer, G. J., Cohen Stuart, M. A., Scheutjens, J. M.
H. M., Cosgrove, T. and Vincent, B., Polymers at Interfaces, Chapman & Hall, London, 1993.
207. Napper, D. H., Polymeric Stabilization of Colloidal Dispersions, Academic Press, London, 1983.
208. Malmsten, M. and Lindman, B., Ellipsometry studies of cellulose ethers, Langmuir, 6, 357-364 (1990).
209. Tiberg, F., Malmsten, M., Linse, P. and Lindman, B., Kinetic and equilibrium aspects of block copolymer adsorption, Langmuir, 7, 2723-2730 (1991).
210. Sakuma, S., Suzuki, N., Kikuchi, H., Hiwatari, K. L, Arikawa, K., Kishida, A. and Akashi, M., Absorption enhancement of orally administered salmon calci-tonin by polystyrene nanoparticles having poly(N-isopropylacrylamide) branches on their surfaces, Int. J.
Pharm., 158, 69-78 (1997).
211. Sakuma, S., Sudo, R., Suzuki, N., Kikuchi, H., Akashi, M.
and Hayashi, M., Mucoadhesion of polystyrene nanopar-ticles having surface hydrophilic polymeric chains in the gastrointestinal tract, Int. J. Pharm., 177, 161-172 (1999).
212. Karlstrom, G., Carlsson, A. and Lindman, B., Phase dia-grams of nonionic polymer-water systems. Experimental and theoretical studies of the effects of surfactants and other cosolutes, J. Phys. Chem., 94, 5005-5015 (1990).
213. Kokufuta, E., Suzuki, H. and Sakamoto, D., On the local binding of ionic surfactants to poly(N-isopropylacry-lamide) gels, Langmuir, 13, 2627-2632 (1997).
214. Dhara, D. and Chatterji, P. R., Effect of hydrotropes on the volume phase transition in poly(A^-isopropylacry-lamide) hydrogel, Langmuir, 15, 930-935 (1999).
215. Carlsson, F., Elofsson, U., Arnebrant, T. and MaIm-sten, M., Interactions between local anaesthetic agents and poly (AMsopropylacrylamide) through phase beha-viour, surface tension, and adsorption measurement, J.
Colloid Interface ScL, 233, 320-328 (2001).
216. Lowe, T. L., Virtanen, J. and Tenhu, H., Interactions of drugs and spin probes with hydrophobically modified polyelectrolyte hydrogels based on N-isopropylacrylamide, Polymer, 40, 2595-2603 (1999).
217. Carelli, V., Coltelli, S., Di Colo, G., Nannipieri, E. and Serafini, M. F., Silicone microspheres for pH-controlled gastrointestinal drug delivery, Int. J. Pharm., 179, 73-83 (1999).
218. Bilia, A., Carelli, V., Di Colo, G. and Nannipieri, E., In vitro evaluation of a pH-sensitive hydrogel for control of GI drug delivery from silicone-based matrices, Int. J.
Pharm., 130, 83-92 (1996).
219. Morris, G. E., Vincent, B. and Snowden, M. J., Adsorp-tion of lead ions on to Af-isopropylacrylamide and acrylic acid copolymer microgels, J. Colloid Interface Sci., 190, 198-205 (1997).
220. Saunders, B. R., Crowther, H. M. and Vincent, B., PoIy-[(methylmethacrylate)-co-(methacrylic acid)] microgel particles: swelling control using pH, cononsolvency, and osmotic deswelling, Macromolecules, 30, 482-487 (1997).
221. Kiser, P. F., Wilson, G. and Needham, D., A synthetic mimic of the secretory granule for drug delivery, Nature, 394, 459-462 (1998).
222. Buonaguidi, M., Carelli, V., Di Colo, G., Nannipieri, E.
and Serafini, M. F., Evalution of a pH-sensitive semi-interpenetrating polymer network for control of GI drug delivery, Int. J. Pharm., 147, 1-10 (1997).
223. Park, H.-Y., Song, L-H., Kim, L-H. and Kim, W.-S., Preparation of thermally denatured albumin gel and its pH-sensitive swelling, Int. J. Pharm., 175, 231-236 (1998).
224. Conaghey, O. M., Corish, L and Corrigan, O. L, The release of nicotine from a hydrogel containing ion exchange resins, Int. J. Pharm., 170, 215-224 (1998).
225. Schacht, E., Goethals, E., Gyselinck, P. and Thien-pont, D., Polymer drug combinations VI. Sustained release of levamisole from ion exchange resins, J. Pharm.
BeIg., 37, 183-188 (1982).
226. Raghunathan, Y., Amsel, L., Hinsvark, O. and Bryant, W., Sustained-release drug delivery system I: coated ion-exchange resin system for phenylpropanolamine and other drugs, J. Pharm. ScL, 70, 379-384 (1981).
227. Irwin, W. L, MacHale, R. and Watts, P. L, Drug-delivery by ion-exchange. Part VII: Release of acidic drugs from anionic exchange resinate complexes, Drug Dev. Ind.
Pharm., 16, 883-898 (1990).
228. Fernandez-Hervas, M. L, Holgado, M. A., Fini, A. and Fell, J. T., In vitro evaluation of alginate beads of a diclofenac salt, Int. J. Pharm., 163, 23-34 (1998).
229. Hwang, S.-L, Rhee, G. L, Lee, K. M., Oh, K.-H. and Kim, C-K., Release characteristics of ibuprofen from excipient-loaded alginate gel beads, Int. J. Pharm., 116, 125-128 (1995).
230. Huguet, M. L. and Dellacherie, E., Calcium alginate beads coated with chitosan: effect of the structure of encapsulated materials on their release, Process Biochem., 31, 745-751 (1996).
231. Lim, L. Y. and Wan, L. S. C , Propranolol hydrochloride binding in calcium alginate beads, Drug Dev. Ind. Pharm., 23, 973-980 (1997).
232. Leong, K. W., Synthetic biodegradable polymer drug delivery systems, in Polymers for Controlled Drug Delivery, Tarcha, P. L (Ed.) CRC Press, Boca Raton, FL,
1991, pp. 127-148.
233. Bruck, S. D. (Ed.), Controlled Drug Delivery, CRC Press, Boca Raton, FL, 1983.
234. Belbella, A., Vauthier, C , Fessi, H., Devissaguet, L-P.
and Puisieux, F., In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities, Int. J. Pharm., 129, 95-102 (1996).
235. Wallis, K. H. and Miiller, R. H., Comparative measure-ments of nanoparticle degradation velocity using an accel-erated hydrolysis test, Pharm. Ind., 55, 168-170 (1993).
236. Bamford, C. H. and Tipper, C. F. H., Ester formation and hydrolysis and related reactions, in Chemical Kinetics, Vol. 10, Bamford, C. H. and Tipper, C. F. H. (Eds), Elsevier, Amsterdam, 1972, pp. 146-161.
237. Domb, A. and Langer, R., Poly anhydrides: stability and novel composition, Makromol. Chem., Macromol. Symp., 19, 189-200 (1988).
238. Sung, K. C , Han, R.-Y., Hu, O. Y. P. and Hsu, L.-R., Controlled release of nalbuphine prodrugs from bio-degradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition, Int. J. Pharm., 172, 17-25 (1998).
239. Miyajima, M., Koshika, A., Okada, L, Kusai, A. and Ikeda, M., The effects of drug physico-chemical properties on release from copoly (lactic/glycolic acid) matrix, Int. J. Pharm., 169, 255-263 (1998).
240. Cha, Y. and Pitt, C. G., The acceleration of degradation-controlled drug delivery from polyester microspheres, J.
Controlled Release, 8, 259-265 (1989).
241. Li, S., Girod-Holland, S. and Vert, M., Hydrolytic degradation of poly(DL-lactic acid) in the presence of caffeine base, /. Controlled Release, 40, 41-53 (1996).
242. O'Hagan, D. T., Microparticles as oral vaccines, in Novel Delivery Systems. Oral Vaccines, O'Hagan, D. T. (Ed.), CRC Press, Boca Raton, FL, 1994, pp. 175-205.
243. Bhagat, H. R., Dalai, P. S. and Nellore, R., Oral vacci-nation by microspheres, Drugs Pharm. ScL, 77, 381-399 (1996).
244. Ray, R., Novak, M., Duncan, J. D., Matsuoka, Y. and Compans, R. W., Microencapsulated human parain-fluenza viruses induce a protective immune response, J.
Infect. Dis., 167, 752-755 (1993).
245. Stevens, V. C , Future perspectives for vaccine develop-ment, Scand. J. Immunol, 36, 137-143 (1992).
246. Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R. and Gilley, R. M., Biodegradable microspheres as a vaccine delivery system, MoI.
Immunol, 28, 287-294 (1991).
247. McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M. and Kiyono, H., The mucosal immune system: from fundamental concepts to vaccine development, Vaccine, 10, 75-88 (1992).
248. Moldoveanu, Z., Novak, M., Huang, W.-Q., Gilley, R. M., Staas, J. K., Schafer, D., Compans, R. W. and Mestecky, J., Oral immunization with influenza virus in biodegradable microspheres, J. Infect. Dis., 167, 84-90 (1993).
249. Eldridge, J. H., Gilley, R. M., Staas, J. K., Moldo-veanu, Z., Meulbroek, J. A. and Tice, T. R., Biodegrad-able microspheres: vaccine delivery system for oral immunization, Curr. Topics Microbiol Immunol, 146, 59-66 (1989).
250. Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R. and Gilley, R. M., Biodegradable and biocom-patible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect.
Immun., 59, 2978-2986 (1991).
251. Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D. and Eldridge, J. H., Protection against vaginal SIV transmission with microencapsulated vaccine, Sci-ence, 260, 1323-1327 (1993).
252. Burke, C. J., Hsu, T.-A. and Volkin, D. B., Formulation, stability, and delivery of live attenuated vaccines for human use, Crit. Rev. Ther. Drug Carrier SySt., 16, 1-83 (1999).
253. Strannegard, 6 . and Yurchision, A., Formation of agglu-tinating and reaginic antibodies in rabbits following oral administration of soluble and particulate antigens, Int.
Arch. Allergy, 35, 579-590 (1969).
254. Cox, D. S. and Taubman, M. A., Oral induction of the secretory antibody response by soluble and particulate antigens, Int. Arch. Allergy Appl. Immun., 75, 126-131 (1984).
255. Nellore, R. V., Pande, P. G., Young, D. and Bhagat, H. R., Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen, J.
Parenteral ScL Technol, 46, 176-180 (1992).
256. Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M. and Tice, T. R., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administrered biodegradable microspheres target the Peyer's patches, /. Controlled Release, 11, 205-214 (1990).
257. Mauduit, J., Bukh, N. and Vert, M., Gentamycin/poly-(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers, /. Controlled Release, 23, 209-220 (1993).
258. Mestecky, J., Moldoveanu, Z., Novak, M., Huang, W.-Q., Gilley, R. M., Staas, J. K., Schafer, D. and Com-pans, R. W., Biodegradable microspheres for the deliv-ery of oral vaccines, /. Controlled Release, 28, 131-141 (1994).
259. Paul, W. E. (Ed.), Fundamental Immunology, Raven Press, New York, 1993.
260. Stevens, V. C , Powell, J. E., Rickey, M., Lee, A. C.
and Lewis, D. H., Studies various delivery systems for a human chorionic gonadotropin vaccine, in Gamete Interaction: Prospects for lmmunocontraception, Wiley, New York, 1990, pp. 549-563.
261. Zhao, X. and Harris, J. M., Novel Degradable PoIy-(ethylene glycol) Esters for Drug Delivery, Harris, J. M.
and Zalipsky, S. (Eds), ACS Symposium Series 680, American Chemical Society, Washington, DC, 1997.
262. Singh, M., Rathi, R., Singh, A., Heller, J., Talwar, G. P.
and Kopecek, J., Controlled release of LHRH-DT from bioerodible hydrogel microspheres, Int. J. Pharm., 76, R5-R8 (1991).
263. Rubinstein, A. and Sintov, A., Biodegradable polymeric matrices with potential specificity to the large intestine, in Oral Colon-Specific Drug Delivery Friend, D. R. (Ed.), CRC Press, Boca Raton, FL, 1992, pp. 233-257.
264. Muller, D., Malmsten, M., Tenodekaew, S. and Booth, C , Adsorption of diblock copolymers of poly(ethylene oxide) and polylactide at hydrophobized silica from aqueous solution, J. Colloid Interface ScL, 228, 326-334 (2000).
265. Kirpotin, D., Hong, K., Mullah, N., Papahadjopoulos, D.
and Zalipsky, S., Liposomes with detachable polymer coatings: destabilization and fusion of dioleoylphos-phatidylethanolamine vesicles triggered by cleavage of surface-grafted polyethylene glycol), FEBS Lett., 388, 115-188 (1996).
266. Hyde, S. T., Andersson, S., Ericsson, B. and Larsson, K., A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glycerolmonooleat-water system, Z. Kristallogr., 168, 213-219 (1984).
267. Nyqvist-Mayer, A. A., Brodin, A. F. and Frank, S. G., Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase, J. Pharm. ScL, 75, 365-373 (1986).